Unit I KANDLA, GUJARAT Formulation Facility
Facility Capabilities
Dosage form |
Units/Annum |
---|---|
Tablets |
10 Million |
Coated Tablets |
1 Million |
General Capsules |
788 Million |
β-Lactum Capsules |
613 Million |
Sachet |
221 Million |
β-Lactum dry Syrup |
26 Million |
Vials |
53 Million |
Glass Ampoule |
48 Million |
Plastic Ampoule |
1.5 Million |
Cream & Ointment |
11 Millions |
Approved by
- WHO (India)
- State GMP
- South Africa(MCC/SAHPRA)
- Kenya - PPB
- India - CDSCO


Unit II KANDLA, GUJARAT Formulation Facility
Facility Capabilities
Dosage form |
Units/Annum |
---|---|
Transdermal Patches |
10.8 Million |
GMP certification
- State GMP


DEHRADUN, UTTARAKHAND Formulation Facility
Facility Capabilities
Dosage form |
Units/Annum |
---|---|
Tablets |
4300 Million |
Capsules |
21 Million |
Sachet |
21 Million |
Transdermal Patches |
8.64 Million |
Granules |
4000 kg |
Vials |
40 Million |
Bottles |
0.1 Million |
Ampoule |
90 Million |
Pre Filled Syring |
15 Million |
Syrup |
9.36 Millions Bottles |
Approved by
- WHO (India)
- IDA
- State GMP
- Ukraine – PIC/S
- Kenya - PPB
- Namibia
- Tanzania - TFDA
- HEALTH CANADA
Ankleshwar, GUJARAT API Facility
API Manufacturing facility is Approved by:
- EDQM - Spain
- WHO (India)
- State GMP
- HEALTH CANADA